Status:
NOT_YET_RECRUITING
Standardization of Spatial Neglect Assessment Tests
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Perceptual Disorders
Healthy Volunteers
Eligibility:
All Genders
20-89 years
Phase:
NA
Brief Summary
Spatial neglect is a common cognitive disorder in stroke patients, characterized by a lateralized deficit in attention and intention. This research focuses on defining norms for tests to assess spati...
Detailed Description
Spatial neglect is a loss of attention to stimuli in the absence of sensory damage. It is most often a left egocentric hemineglect, due to involvement of the right perisylvian cortex, in which the pat...
Eligibility Criteria
Inclusion
- Healthy volunteer attending the neurovascular department of Raymond-Poincaré Hospital
- Aged between 20 and 89 years
- Affiliated with a health insurance scheme
- French-speaking
- Has freely and knowingly expressed their non-opposition
Exclusion
- Known history of central neurological disease: stroke (ischemic or hemorrhagic), transient ischemic attack, encephalitis, multiple sclerosis, or epilepsy.
- Medical interview suggesting past central nervous system involvement: history of episodes such as sensorimotor deficits, dysarthria, aphasia, blurred or double vision, or positive symptoms such as visual or sensory hallucinations (e.g., paresthesias).
- Significant visual impairment - as judged by the examiner - in near vision despite correction, or monocular blindness. Specifically, inability to distinguish the targets with gaps in the example (pre-test) of the Apples Cancellation Test.
- Abnormal neurological examination:
- National Institutes of Health Stroke Scale (NIHSS) score \> 0
- Pyramidal reflex syndrome (hyperactive deep tendon reflexes with extended reflexogenic zones and spread).
- Use of substances (alcohol or drugs) within 24 hours prior to the assessment.
- Presence of cognitive or psychiatric disorders, assessed during the inclusion interview and neurological examination, at the examiner's discretion.
- Language barrier or aphasia, assessed during the inclusion interview and neurological examination, at the examiner's discretion.
- Participant under legal protection (guardianship, curatorship, or legal safeguard).
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT07145970
Start Date
October 1 2025
End Date
October 1 2026
Last Update
August 28 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.